Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Volume 317, Issue 4, Pages E658-E666
Publisher
American Physiological Society
Online
2019-08-14
DOI
10.1152/ajpendo.00204.2019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protective Effects of Oxymatrine on Vascular Endothelial Cells from High-Glucose-Induced Cytotoxicity by Inhibiting the Expression of A2B Receptor
- (2018) Yun Yi et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production
- (2018) Daigo Sawaki et al. CIRCULATION
- Prognostic significance of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease
- (2018) Gerasimos Siasos et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease
- (2018) Tuula Saukkonen et al. Scientific Reports
- Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension
- (2016) Tomasz P. Mikolajczyk et al. FASEB JOURNAL
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome
- (2015) Francesca Schinzari et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Metabolic Syndrome Individuals With and Without Type 2 Diabetes Mellitus Present Generalized Vascular DysfunctionSignificance
- (2015) Guillaume Walther et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Vascular calcification: from pathophysiology to biomarkers
- (2015) Séverine Evrard et al. CLINICA CHIMICA ACTA
- Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism
- (2015) Giuseppe Daniele et al. DIABETES CARE
- Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile
- (2015) I Barchetta et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Comparative Effect of Pioglitazone and Metformin on Serum Osteoprotegerin, Adiponectin and Intercellular Adhesion Molecule Concentrations in Patients with Newly Diagnosed Type 2 Diabetes: a Randomized Clinical Trial
- (2015) A. Esteghamati et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Osteoprotegerin in Cardiometabolic Disorders
- (2015) C. Pérez de Ciriza et al. International Journal of Endocrinology
- RANKL–OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy
- (2014) Agbor Ndip et al. DIABETOLOGIA
- Fetuin-A: a novel link between obesity and related complications
- (2014) J F Trepanowski et al. INTERNATIONAL JOURNAL OF OBESITY
- CCL5/RANTES is important for inducing osteogenesis of human mesenchymal stem cells and is regulated by dexamethasone
- (2014) Yu-Chuan Liu et al. BioScience Trends
- The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus
- (2013) G. Daniele et al. ACTA DIABETOLOGICA
- Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease
- (2013) A.E. Berezin et al. ATHEROSCLEROSIS
- Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes
- (2013) D. Gordin et al. DIABETES CARE
- Diagnosis and Classification of Diabetes Mellitus
- (2013) DIABETES CARE
- Rosiglitazone Decreases Plasma Levels of Osteoprotegerin in a Randomized Clinical Trial with Type 2 Diabetes Patients
- (2011) Mads Nybo et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humans
- (2011) K. A. Han et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
- (2010) Jong Suk Park et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Regulatory mechanisms in vascular calcification
- (2010) Andrew P. Sage et al. Nature Reviews Cardiology
- Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis
- (2010) Matthias Barton PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Getting the message across: mechanisms of physiological cross talk by adipose tissue
- (2009) Do-Eun Lee et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- RANTES release by human adipose tissue in vivo and evidence for depot-specific differences
- (2009) Rana Madani et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Release of 12 Adipokines by Adipose Tissue, Nonfat Cells, and Fat Cells From Obese Women
- (2009) John N. Fain et al. Obesity
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search